A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training
- Conditions
- HemiparesisStroke
- Interventions
- Device: rTMSBehavioral: BCI Training
- Registration Number
- NCT02132520
- Lead Sponsor
- University of Minnesota
- Brief Summary
The purpose of this study is to determine whether the combination of low frequency repetitive transcranial magnetic stimulation (rTMS) and motor-imagery-based brain computer interface (BCI) training is effective for enhancing motor recovery after stroke.
The PI's hypothesis is that, in comparison with traditional physical therapy alone, subjects receiving supplementary rTMS and BCI training will show greater functional improvements in hand motor ability over time as well as recovery of normal motor connectivity patterns.
- Detailed Description
The goal of the present study is to develop and evaluate a brain based approach to improve motor recovery after stroke, by combining rTMS and BCI training. Treatments will consist of low frequency rTMS applied to the contralesional hemisphere, followed by BCI training to encourage activity within the lesioned hemisphere. The primary objective of this study is to test the main hypothesis above in a stroke patient population. Subjects will also undergo a period of BCI only treatments after completion of the combined rTMS and BCI portion.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3
- 18-70 years of age
- Cortical or subcortical stroke with isolated unilateral motor paresis
- At least 3 months but no greater than 12 months post stroke and in stable conditions as judged by patient's physician
- Impaired hand function compared to nonparetic side but at least 10 degrees of active finger extension
- Able to ambulate at least 50 feet with minimal stand-by assistance
- Upper Extremity Fugl Meyer (Fugl-Meyer et al., 1975) score of greater than or equal to 20 out of 66
- Beck Depression Inventory (Beck et al., 1961) less than or equal to 19 out of 63
- Mini-mental State Examination score (Folstein et al., 1975) greater than or equal to 24 out of 30
- Must have an ipsilesional motor-evoked potential (MEP) in response to TMS
- Must be stable outpatients currently undergoing rehabilitation consistent with the current standards of care
- Must be able to communicate clearly in English
- Must be able to provide consent in writing.
- Personal history of epilepsy or seizures within the past 2 years
- Previous surgical procedure to the spinal cord
- Any MRI incompatible devices
- Pregnancy
- Claustrophobia
- Breathing disorder
- Hearing problems or ringing in the ears
- Bilateral motor paresis or paralysis or those patients that would require significant medical monitoring or management beyond that of a stable outpatient
- Cognitive deficits, other non-motor neurological impairment, bilateral motor paresis or paralysis or those patients that would require significant medical monitoring or management beyond that of a stable outpatient
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Real rTMS + Real BCI Training BCI Training Subjects will receive real rTMS followed by real BCI training. Sham rTMS + Real BCI Training rTMS Subjects will receive sham rTMS followed by real BCI training. Real rTMS + Real BCI Training rTMS Subjects will receive real rTMS followed by real BCI training. Sham rTMS + Real BCI Training BCI Training Subjects will receive sham rTMS followed by real BCI training.
- Primary Outcome Measures
Name Time Method Changes in Cortical Excitability and Cortical Activation Patterns as Measured by MRI and Functional MRI Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks) The MRI and functional MRI will evaluate the extent to which cortical areas are recruited both during rest and during movement related tasks. This is quantified by a laterality index, calculated as the ratio of activations of ipsi- and contra-lesional precentral gyri during a paretic hand tracking task. A LI of -1 corresponds to entirely contralesional activation, while a value of +1 corresponds to entirely ipsilesional activation.
- Secondary Outcome Measures
Name Time Method Changes in Hand Motor Function as Measured by the Box and Block Test Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks) Performance on the box and block test with the paretic hand, quantified as the number of 2.5 cm\^3 cubes grasped, lifted, and released to transfer between compartments correctly within 60 seconds.
Changes in Paretic Hand Motor Function as Measured by the Finger Tracking Test Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks) The finger tracking test evaluates the subject's ability to track an oscillating wave with either their paretic or non-paretic finger. Subjects wore custom electro-goniometer braces on each hand, each of which included a potentiometer signaling extension and flexion of the index finger metacarpophalangeal joint. Subjects were presented with target stimuli with a random sinusoidal waveform and were instructed to move the corresponding index finger to match the target trace as the cursor moved across the screen with constant velocity. Performance was quantified by an accuracy index, calculated using the ratio of the error to the standard deviation of the target, normalized to the range of motion for each subject.
Changes in Inter-hemispheric Inhibition Baseline, Post-Test 1 (3 weeks), Post-Test 2 (6 weeks) Inter-hemispheric Inhibition was evaluated using paired-pulse TMS both for the stroke hemisphere to non-stroke hemisphere direction as well as for the non-stroke hemisphere to the stroke hemisphere direction. IHI was measured by applying TMS to identified left and right motor hotspots at 1 mV threshold intensity, or 130% of the RMT if 1 mV threshold could not be identified, with single unilateral pulses and paired bilateral pulses. IHI was quantified by comparing the paired-pulse peak-to-peak motor evoked potential amplitudes to the corresponding single pulse MEP amplitudes for each direction of stimulation (ipsi- to contra-lesional and contra- to ipsi-lesional).
Trial Locations
- Locations (1)
Clinical and Translational Science Institute
🇺🇸Minneapolis, Minnesota, United States